Medical and research translation (MART) building
The construction of the Medical and Research Translation (MART) building at the Stony Brook University (SBU) medical centre campus began in November 2013. The building is being constructed at Long Island in New York, US.
Upon its completion in 2018, the new building will feature a cancer research centre as well as facilities for advanced medical imaging, neurosciences and cancer care.
The eight-storey MART building will have a total floor space of 250,000ft². It will include a modern 300-seat auditorium, 25 cancer biology-oriented labs, and 30-room cancer clinic. It will also feature a 30-station clinical infusion centre, breakout rooms for smaller conferences, and 12 new classrooms for students.
The new facility will house advanced biomedical imaging and biomedical informatics, including a PET/CT scanner. It will have space dedicated to carry out translation research with multi-disciplinary collaboration to take basic research from the lab, through clinical trials and to the marketplace for direct patient care.
Construction of a new biomedical research facility known as Health Sciences Facility III (HSF III) began at the University of Maryland campus in September 2013.
The new facility will expand healthcare services and research in the Long Island region and is expected to generate 4,200 project-related and specialised research jobs. It is also expected to enhance the economic growth of the Long Island region.
The MART facility will be situated next to a new 225,000ft² support tower known as the ‘bed tower’, which will house the 150-bed Stony Brook Children’s Hospital. The bed tower will have ten levels to enable scientists and physicians to work together, advancing cancer research and imaging diagnostics. The new tower will include a paediatric intensive care unit, adolescent unit, procedure suite, haematology or oncology unit, medical or surgical units, and modern patient and family amenities.
The main façade of the MART building will feature a glass curtain wall with vertical stripe patterns. The building will be covered by a metal panel system, and strip windows on the building will highlight the research lab areas. The glass façade of the auditorium will have a large Stony Brook logo written in a red ceramic frit pattern.
The design for the MART building was provided by Pelli Clarke Pelli Architects in collaboration with AECOM.
AECOM Technology Corporation was contracted to provide planning, medical engineering, design and project management services for the project in January 2013. The contractual scope also included providing interior fit-out, cost estimates, project cost model and risk registry services.
EW Howell was awarded a $161m contract to provide general contraction and construction management services at the facility in January 2014. LiRo Group is providing construction management services for the project. Shen Milsom & Wilke was contracted to provide medical equipment planning, information technology, security, audiovisual and acoustical services.
Bana Electric Corp. (BEC) was contracted to provide electrical systems for the project.
The total investment for the construction of the MART building is estimated to be about $194m. It is the first to be constructed as part of the $423m SBU medicine expansion project that will advance research and clinical care.
Dr James and Dr Marilyn Simons and the Simons Foundation gifted $150m to the SBU, of which $50m will be spent on the MART project. Governor Andrew Cuomo and the State University of New York (SUNY) contributed $35m for the construction of the facility as part of the NYSUNY 2020 challenge grant.
Thermo Fisher Scientific (Thermo Fisher) will establish a new pharmaceutical services facility for integrated biologics and sterile drug development and…
Arranta Bio is constructing a new multi-product, commercial-ready manufacturing facility in Watertown, Massachusetts, US. Watertown facility will be used for…
Berkshire Sterile Manufacturing (BSM) is expanding its manufacturing facility in Lee, Massachusetts (MA), US. The company began preparations for the…
Lykan Bioscience opened a purpose-built SMART Manufacturing™ facility for developing cell-based therapies in Hopkinton, Massachusetts, US, in September 2020. The…